-
Researchers mine data and connect the dots about processes driving neuroblastoma
10/14/2020
St. Jude Children’s Research Hospital scientists lead genome analysis to better understand one of the most common childhood solid tumors.
-
St. Jude achieves Magnet® designation for nursing services for the second time
10/12/2020
Magnet® designation is the highest honor bestowed in nursing and serves as a benchmark for patients to measure the quality of nursing care they can expect to receive at a hospital.
-
St. Jude recognized as clinical care center for rare von Hippel-Lindau syndrome
09/30/2020
St. Jude is the first and only VHL Alliance-recognized Clinical Care Center dedicated solely to children.
-
St. Jude immunologist Thirumala-Devi Kanneganti, Ph.D., receives NCI Outstanding Investigator Award
09/24/2020
The National Cancer Institute award provides extended support for researchers to pursue projects with groundbreaking cancer research potential
-
Building bridges: PARP enzymes bring broken DNA together
09/16/2020
St. Jude researchers capture the structure of PARP enzymes at work, leading to a new understanding of DNA repair that may aid cancer treatments targeting the process.
-
Inherited genetic variant influences response to leukemia treatment for some children
09/11/2020
St. Jude researchers showed that an inherited variant of the GATA3 gene is tied to minimal residual disease levels and response to therapy for ALL
-
Want to block flu transmission? Targeting nasal bacteria may help
09/09/2020
St. Jude Children’s Research Hospital scientists report that respiratory bacteria aid spread of flu virus .
-
Screenings for cardiac dysfunction among childhood cancer survivors can be more precisely tailored
08/14/2020
New guidelines may be warranted for childhood cancer survivors at low and high risk of cardiac late effects.
-
Targeting the LANDO pathway holds a potential clue to treating Alzheimer’s disease
08/14/2020
Reducing neuroinflammation by disrupting a protein involved in recycling cellular components may provide a potential therapeutic approach for treating neurodegeneration and memory loss.
-
John Crispino named to head the Division of Experimental Hematology at St. Jude
08/13/2020
Crispino’s research focuses on acute leukemia in children with Down syndrome and blood cell development
Explore more research news
More Research News
-
Scientific Report 2019
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Promise Magazine
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.